KARLA MARVICH: Open Payments
NPI 1649522178 · EUGENE, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,342 in 67 payments from 12 companies in 2025. Trend: 2023 $1,228 · 2024 $796 · 2025 $1,342
Food & beverage: $1,342
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $346 |
| Otsuka America Pharmaceutical, Inc. | 14 | $188 |
| Alkermes, Inc. | 11 | $183 |
| ABBVIE INC. | 10 | $182 |
| Vanda Pharmaceuticals Inc. | 6 | $134 |
| Axsome Therapeutics, Inc. | 5 | $111 |
| Lundbeck LLC | 3 | $62 |
| E.R. Squibb & Sons, L.L.C. | 3 | $52 |
| Braeburn Inc. | 1 | $24 |
| Supernus Pharmaceuticals, Inc. | 1 | $24 |
Products named: CAPLYTA, REXULTI, VRAYLAR, ARISTADA, FANAPT, Auvelity, ABILIFY ASIMTUFII, COBENFY.
Industry payments across OR — which companies pay providers there.
